Children with screening-detected coeliac disease show increased levels of nitric oxide products in urine
Aim: Increased concentration of nitric oxide (NO) metabolites, nitrite and nitrate, in the urine is a strong indication of ongoing small intestinal inflammation, which is a hallmark of the enteropathy of coeliac disease (CD). It has previously been shown that children with symptomatic, untreated CD...
Saved in:
Published in | Acta Paediatrica Vol. 100; no. 7; pp. 1023 - 1027 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.07.2011
Blackwell Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 0803-5253 1651-2227 1651-2227 |
DOI | 10.1111/j.1651-2227.2011.02186.x |
Cover
Abstract | Aim: Increased concentration of nitric oxide (NO) metabolites, nitrite and nitrate, in the urine is a strong indication of ongoing small intestinal inflammation, which is a hallmark of the enteropathy of coeliac disease (CD). It has previously been shown that children with symptomatic, untreated CD have increased levels of NO oxidation products in their urine. The aim of this study was to investigate whether screening‐detected, asymptomatic coeliac children display the same urinary nitrite/nitrate pattern.
Methods: In a multicenter screening study, serum samples were collected from 7208 12‐year‐old children without previously diagnosed CD. Sera were analysed for anti‐human tissue transglutaminase (tTG) of isotype IgA. Small bowel biopsy was performed in antibody‐positive children, yielding 153 new cases of CD. In the screening‐detected individuals, the sum of nitrite and nitrate concentrations in the urine was analysed and used as an indicator of NO production. For comparison, 73 children with untreated, symptomatic CD were studied.
Results: The nitrite/nitrate levels in children with screening‐detected CD and those with untreated symptomatic CD did not differ significantly. Both groups had significantly increased urinary nitrite/nitrate concentrations compared to the children with normal small bowel biopsy (p < 0.001).
Conclusion: Children with screening‐detected CD have increased production of NO just as children with untreated symptomatic CD. High NO metabolite levels in the urine may indicate a pathogenetic feature of CD and be a marker of major clinical importance. |
---|---|
AbstractList | Aim: Increased concentration of nitric oxide (NO) metabolites, nitrite and nitrate, in the urine is a strong indication of ongoing small intestinal inflammation, which is a hallmark of the enteropathy of coeliac disease (CD). It has previously been shown that children with symptomatic, untreated CD have increased levels of NO oxidation products in their urine. The aim of this study was to investigate whether screening-detected, asymptomatic coeliac children display the same urinary nitrite/nitrate pattern. Methods: In a multicenter screening study, serum samples were collected from 7208 12-year-old children without previously diagnosed CD. Sera were analysed for anti-human tissue transglutaminase (tTG) of isotype IgA. Small bowel biopsy was performed in antibody-positive children, yielding 153 new cases of CD. In the screening-detected individuals, the sum of nitrite and nitrate concentrations in the urine was analysed and used as an indicator of NO production. For comparison, 73 children with untreated, symptomatic CD were studied. Results: The nitrite/nitrate levels in children with screening-detected CD and those with untreated symptomatic CD did not differ significantly. Both groups had significantly increased urinary nitrite/nitrate concentrations compared to the children with normal small bowel biopsy (p andlt; 0.001). Conclusion: Children with screening-detected CD have increased production of NO just as children with untreated symptomatic CD. High NO metabolite levels in the urine may indicate a pathogenetic feature of CD and be a marker of major clinical importance. Aim: Increased concentration of nitric oxide (NO) metabolites, nitrite and nitrate, in the urine is a strong indication of ongoing small intestinal inflammation, which is a hallmark of the enteropathy of coeliac disease (CD). It has previously been shown that children with symptomatic, untreated CD have increased levels of NO oxidation products in their urine. The aim of this study was to investigate whether screening-detected, asymptomatic coeliac children display the same urinary nitrite/nitrate pattern. Methods: In a multicenter screening study, serum samples were collected from 7208 12-year-old children without previously diagnosed CD. Sera were analysed for anti-human tissue transglutaminase (tTG) of isotype IgA. Small bowel biopsy was performed in antibody-positive children, yielding 153 new cases of CD. In the screening-detected individuals, the sum of nitrite and nitrate concentrations in the urine was analysed and used as an indicator of NO production. For comparison, 73 children with untreated, symptomatic CD were studied. Results: The nitrite/nitrate levels in children with screening-detected CD and those with untreated symptomatic CD did not differ significantly. Both groups had significantly increased urinary nitrite/nitrate concentrations compared to the children with normal small bowel biopsy (p < 0.001). Conclusion: Children with screening-detected CD have increased production of NO just as children with untreated symptomatic CD. High NO metabolite levels in the urine may indicate a pathogenetic feature of CD and be a marker of major clinical importance. [PUBLICATION ABSTRACT] Increased concentration of nitric oxide (NO) metabolites, nitrite and nitrate, in the urine is a strong indication of ongoing small intestinal inflammation, which is a hallmark of the enteropathy of coeliac disease (CD). It has previously been shown that children with symptomatic, untreated CD have increased levels of NO oxidation products in their urine. The aim of this study was to investigate whether screening-detected, asymptomatic coeliac children display the same urinary nitrite/nitrate pattern.AIMIncreased concentration of nitric oxide (NO) metabolites, nitrite and nitrate, in the urine is a strong indication of ongoing small intestinal inflammation, which is a hallmark of the enteropathy of coeliac disease (CD). It has previously been shown that children with symptomatic, untreated CD have increased levels of NO oxidation products in their urine. The aim of this study was to investigate whether screening-detected, asymptomatic coeliac children display the same urinary nitrite/nitrate pattern.In a multicenter screening study, serum samples were collected from 7208 12-year-old children without previously diagnosed CD. Sera were analysed for anti-human tissue transglutaminase (tTG) of isotype IgA. Small bowel biopsy was performed in antibody-positive children, yielding 153 new cases of CD. In the screening-detected individuals, the sum of nitrite and nitrate concentrations in the urine was analysed and used as an indicator of NO production. For comparison, 73 children with untreated, symptomatic CD were studied.METHODSIn a multicenter screening study, serum samples were collected from 7208 12-year-old children without previously diagnosed CD. Sera were analysed for anti-human tissue transglutaminase (tTG) of isotype IgA. Small bowel biopsy was performed in antibody-positive children, yielding 153 new cases of CD. In the screening-detected individuals, the sum of nitrite and nitrate concentrations in the urine was analysed and used as an indicator of NO production. For comparison, 73 children with untreated, symptomatic CD were studied.The nitrite/nitrate levels in children with screening-detected CD and those with untreated symptomatic CD did not differ significantly. Both groups had significantly increased urinary nitrite/nitrate concentrations compared to the children with normal small bowel biopsy (p < 0.001).RESULTSThe nitrite/nitrate levels in children with screening-detected CD and those with untreated symptomatic CD did not differ significantly. Both groups had significantly increased urinary nitrite/nitrate concentrations compared to the children with normal small bowel biopsy (p < 0.001). Children with screening-detected CD have increased production of NO just as children with untreated symptomatic CD. High NO metabolite levels in the urine may indicate a pathogenetic feature of CD and be a marker of major clinical importance.CONCLUSION Children with screening-detected CD have increased production of NO just as children with untreated symptomatic CD. High NO metabolite levels in the urine may indicate a pathogenetic feature of CD and be a marker of major clinical importance. Aim: Increased concentration of nitric oxide (NO) metabolites, nitrite and nitrate, in the urine is a strong indication of ongoing small intestinal inflammation, which is a hallmark of the enteropathy of coeliac disease (CD). It has previously been shown that children with symptomatic, untreated CD have increased levels of NO oxidation products in their urine. The aim of this study was to investigate whether screening‐detected, asymptomatic coeliac children display the same urinary nitrite/nitrate pattern. Methods: In a multicenter screening study, serum samples were collected from 7208 12‐year‐old children without previously diagnosed CD. Sera were analysed for anti‐human tissue transglutaminase (tTG) of isotype IgA. Small bowel biopsy was performed in antibody‐positive children, yielding 153 new cases of CD. In the screening‐detected individuals, the sum of nitrite and nitrate concentrations in the urine was analysed and used as an indicator of NO production. For comparison, 73 children with untreated, symptomatic CD were studied. Results: The nitrite/nitrate levels in children with screening‐detected CD and those with untreated symptomatic CD did not differ significantly. Both groups had significantly increased urinary nitrite/nitrate concentrations compared to the children with normal small bowel biopsy (p < 0.001). Conclusion: Children with screening‐detected CD have increased production of NO just as children with untreated symptomatic CD. High NO metabolite levels in the urine may indicate a pathogenetic feature of CD and be a marker of major clinical importance. Increased concentration of nitric oxide (NO) metabolites, nitrite and nitrate, in the urine is a strong indication of ongoing small intestinal inflammation, which is a hallmark of the enteropathy of coeliac disease (CD). It has previously been shown that children with symptomatic, untreated CD have increased levels of NO oxidation products in their urine. The aim of this study was to investigate whether screening-detected, asymptomatic coeliac children display the same urinary nitrite/nitrate pattern. In a multicenter screening study, serum samples were collected from 7208 12-year-old children without previously diagnosed CD. Sera were analysed for anti-human tissue transglutaminase (tTG) of isotype IgA. Small bowel biopsy was performed in antibody-positive children, yielding 153 new cases of CD. In the screening-detected individuals, the sum of nitrite and nitrate concentrations in the urine was analysed and used as an indicator of NO production. For comparison, 73 children with untreated, symptomatic CD were studied. The nitrite/nitrate levels in children with screening-detected CD and those with untreated symptomatic CD did not differ significantly. Both groups had significantly increased urinary nitrite/nitrate concentrations compared to the children with normal small bowel biopsy (p < 0.001). Children with screening-detected CD have increased production of NO just as children with untreated symptomatic CD. High NO metabolite levels in the urine may indicate a pathogenetic feature of CD and be a marker of major clinical importance. Aim: Increased concentration of nitric oxide (NO) metabolites, nitrite and nitrate, in the urine is a strong indication of ongoing small intestinal inflammation, which is a hallmark of the enteropathy of coeliac disease (CD). It has previously been shown that children with symptomatic, untreated CD have increased levels of NO oxidation products in their urine. The aim of this study was to investigate whether screening‐detected, asymptomatic coeliac children display the same urinary nitrite/nitrate pattern. Methods: In a multicenter screening study, serum samples were collected from 7208 12‐year‐old children without previously diagnosed CD. Sera were analysed for anti‐human tissue transglutaminase (tTG) of isotype IgA. Small bowel biopsy was performed in antibody‐positive children, yielding 153 new cases of CD. In the screening‐detected individuals, the sum of nitrite and nitrate concentrations in the urine was analysed and used as an indicator of NO production. For comparison, 73 children with untreated, symptomatic CD were studied. Results: The nitrite/nitrate levels in children with screening‐detected CD and those with untreated symptomatic CD did not differ significantly. Both groups had significantly increased urinary nitrite/nitrate concentrations compared to the children with normal small bowel biopsy (p < 0.001). Conclusion: Children with screening‐detected CD have increased production of NO just as children with untreated symptomatic CD. High NO metabolite levels in the urine may indicate a pathogenetic feature of CD and be a marker of major clinical importance. Aim: Increased concentration of nitric oxide (NO) metabolites, nitrite and nitrate, in the urine is a strong indication of ongoing small intestinal inflammation, which is a hallmark of the enteropathy of coeliac disease (CD). It has previously been shown that children with symptomatic, untreated CD have increased levels of NO oxidation products in their urine. The aim of this study was to investigate whether screening-detected, asymptomatic coeliac children display the same urinary nitrite/nitrate pattern. Methods: In a multicenter screening study, serum samples were collected from 7208 12-year-old children without previously diagnosed CD. Sera were analysed for anti-human tissue transglutaminase (tTG) of isotype IgA. Small bowel biopsy was performed in antibody-positive children, yielding 153 new cases of CD. In the screening-detected individuals, the sum of nitrite and nitrate concentrations in the urine was analysed and used as an indicator of NO production. For comparison, 73 children with untreated, symptomatic CD were studied. Results: The nitrite/nitrate levels in children with screening-detected CD and those with untreated symptomatic CD did not differ significantly. Both groups had significantly increased urinary nitrite/nitrate concentrations compared to the children with normal small bowel biopsy (p < 0.001). Conclusion: Children with screening-detected CD have increased production of NO just as children with untreated symptomatic CD. High NO metabolite levels in the urine may indicate a pathogenetic feature of CD and be a marker of major clinical importance. |
Author | Sundqvist, T Högberg, L Forslund, T Danielsson, L Magnusson, K-E Webb, C Fälth-Magnusson, K Ivarsson, A Sandström, O |
Author_xml | – sequence: 1 givenname: L surname: Högberg fullname: Högberg, L organization: Pediatric Clinic, Norrköping Hospital, Norrköping, Sweden – sequence: 2 givenname: C surname: Webb fullname: Webb, C organization: Department of Pediatrics, Lund University, Lund, Sweden – sequence: 3 givenname: K surname: Fälth-Magnusson fullname: Fälth-Magnusson, K organization: Division of Pediatrics, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden – sequence: 4 givenname: T surname: Forslund fullname: Forslund, T organization: Division of Medical Microbiology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden – sequence: 5 givenname: K-E surname: Magnusson fullname: Magnusson, K-E organization: Division of Medical Microbiology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden – sequence: 6 givenname: L surname: Danielsson fullname: Danielsson, L organization: Pediatric Outpatient Clinic, Norrtälje Hospital, Norrtälje, Sweden – sequence: 7 givenname: A surname: Ivarsson fullname: Ivarsson, A organization: Department of Public Health and Clinical Medicine, Epidemiology and Public Health Sciences, Umeå University, Umeå, Sweden – sequence: 8 givenname: O surname: Sandström fullname: Sandström, O organization: Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden – sequence: 9 givenname: T surname: Sundqvist fullname: Sundqvist, T organization: Division of Medical Microbiology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24243112$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21284717$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-69187$$DView record from Swedish Publication Index https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-42920$$DView record from Swedish Publication Index |
BookMark | eNqNkk-P0zAQxSO0iP0DXwFZQogLKbYTx-4BpKqwBbECDsByG7n2ZOuS2sVOaPfbk2y7RdpTfbFH_r03Gs07z0588JhlhNER68-b5YhVguWccznilLER5UxVo-2j7OzwcZKdUUWLXHBRnGbnKS0p5cW4rJ5kp5xxVUomz7LFdOEaG9GTjWsXJJmI6J2_yS22aFq0xARsnDbEuoQ6IUmLsCHO92BfWdLgX2wSCTXxro3OkLB1Fsk6BtuZNvUk6aLz-DR7XOsm4bP9fZH9uPzwffoxv_o6-zSdXOVGFKrKrWDaMGUslbYquKg11_O5wLk1pULGuVaMKiuU1qqWJZXGssoqo6mwQtSyuMhe73zTBtfdHNbRrXS8haAdvHc_JxDiDXSrDko-5vQ4vHEdVGOmBvdXO7yf70-HqYWVSwabRnsMXQIlleKUyrInXzwgl6GLvh8dmChLJUtxRz3fU918hfbQ_n5BPfByD-hkdFNH7Y1L_7mSlwVjvOfe7TgTQ0oRazCu1a0Lvo3aNcAoDMmBJQwBgSEgMCQH7pID295APTC473GE9O1OunEN3h6tg8m3yfDq9flO71KL24Nex99QyUIKuP4yg-Ly1zWbjRV8Lv4BnvTqAA |
CitedBy_id | crossref_primary_10_3390_antiox12040845 crossref_primary_10_1007_s00580_012_1601_8 crossref_primary_10_26599_FSHW_2024_9250033 crossref_primary_10_1155_2018_1324820 crossref_primary_10_1586_egh_11_79 crossref_primary_10_3390_nu4040243 crossref_primary_10_1016_j_bbadis_2014_04_021 crossref_primary_10_1159_000448664 crossref_primary_10_3389_fmicb_2022_859467 crossref_primary_10_3390_brainsci10070437 crossref_primary_10_1007_s00394_019_02013_5 crossref_primary_10_1155_2012_587479 |
Cites_doi | 10.1080/00365520410003407 10.1097/00005176-200501000-00001 10.1111/j.1365-2567.2004.01984.x 10.1016/j.cccn.2005.01.029 10.1097/MPG.0b013e31815ef87d 10.1016/S0140-6736(09)60254-3 10.1016/j.niox.2005.08.002 10.1186/1471-244X-5-14 10.1111/j.1572-0241.2005.00313.x 10.1136/gut.52.7.960 10.1097/00042737-200310000-00005 10.1006/abio.1995.1079 10.1097/MPG.0b013e3181818fb9 10.1016/j.ejim.2007.05.012 10.1111/j.1651-2227.1999.tb00169.x 10.1136/adc.65.8.909 10.1097/MPG.0b013e31812e5710 10.1097/00005176-199808000-00013 10.1053/j.gastro.2005.02.015 10.1097/MPG.0b013e31817fcb7f 10.1111/j.1365-2036.2008.03612.x 10.1080/003655298750026958 10.1016/0016-5085(92)91819-P 10.1097/MPG.0b013e31818c52cc 10.1080/003655201750065924 10.1136/gut.2006.100511 |
ContentType | Journal Article |
Copyright | 2011 The Author(s)/Acta Pædiatrica © 2011 Foundation Acta Pædiatrica 2015 INIST-CNRS 2011 The Author(s)/Acta Paediatrica © 2011 Foundation Acta Paediatrica. |
Copyright_xml | – notice: 2011 The Author(s)/Acta Pædiatrica © 2011 Foundation Acta Pædiatrica – notice: 2015 INIST-CNRS – notice: 2011 The Author(s)/Acta Paediatrica © 2011 Foundation Acta Paediatrica. |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7T5 7TK 7TM 7TS 7U9 H94 K9. M7N 7X8 ADTPV AOWAS DG8 D93 |
DOI | 10.1111/j.1651-2227.2011.02186.x |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Immunology Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Physical Education Index Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) MEDLINE - Academic SwePub SwePub Articles SWEPUB Linköpings universitet SWEPUB Umeå universitet |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Virology and AIDS Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Neurosciences Abstracts Physical Education Index MEDLINE - Academic |
DatabaseTitleList | Virology and AIDS Abstracts MEDLINE - Academic MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1651-2227 |
EndPage | 1027 |
ExternalDocumentID | oai_DiVA_org_umu_42920 oai_DiVA_org_liu_69187 3371663051 21284717 24243112 10_1111_j_1651_2227_2011_02186_x APA2186 ark_67375_WNG_3FXW1G98_K |
Genre | article Research Support, Non-U.S. Gov't Multicenter Study Journal Article |
GroupedDBID | .55 .GA .GJ 3O- 51W 51X 52N 52O 52P 52R 52T 52W 52X 53G 5GY 5HH 5LA 5RE 66C 7PT 930 A01 A03 AAWTL ABDBF ABJNI ACGFS ACUHS AI. ALMA_UNASSIGNED_HOLDINGS BSCLL BY8 EAD EAP EAS EBC EBD EBX EMB EMK EMOBN EPT ESX F5P LP6 LP7 N9D P4B P4D Q~Q SV3 TUS VH1 WQJ WXI X7M ZGI AAYXX CITATION .3N .Y3 05W 0R~ 10A 1OB 1OC 24P 31~ 33P 36B 3SF 4.4 50Y 50Z 52M 52S 52U 52V 5VS 702 8-0 8-1 8-3 8-4 8-5 8UM AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AAQQT AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIVO ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCMX ACCZN ACGEJ ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXPE ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AFBPY AFFNX AFFPM AFGKR AFRAH AFWVQ AFZJQ AGQPQ AGXDD AGYGG AHBTC AHEFC AHMBA AIACR AIDQK AIDYY AITYG AIURR AJWEG ALAGY ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DUUFO EBS EJD EX3 F00 F01 F04 FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZ~ IQODW IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2W P2X P2Z PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WVDHM WXSBR XG1 ~IA ~WT CGR CUY CVF ECM EIF NPM 7T5 7TK 7TM 7TS 7U9 H94 K9. M7N 7X8 ADTPV AOWAS DG8 D93 |
ID | FETCH-LOGICAL-c5386-d51ac18cd07d6325fa2abb5ebdc48e122a8108d58aa8f7407cd16d8ca05d55f73 |
IEDL.DBID | DR2 |
ISSN | 0803-5253 1651-2227 |
IngestDate | Thu Aug 21 06:41:41 EDT 2025 Thu Aug 21 06:54:40 EDT 2025 Fri Sep 05 13:22:43 EDT 2025 Mon Jun 30 06:58:11 EDT 2025 Thu Apr 03 07:01:22 EDT 2025 Mon Jul 21 09:18:33 EDT 2025 Thu Apr 24 23:08:29 EDT 2025 Tue Jul 01 03:44:29 EDT 2025 Wed Aug 20 07:25:12 EDT 2025 Sun Sep 21 06:18:12 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | Human Urine Immunopathology Pediatrics Nitrites Nitrates Medical screening Coeliac disease Screening Intestinal malabsorption Nitric oxide Digestive diseases Intestinal disease Child Urinary nitrite/nitrate |
Language | English |
License | CC BY 4.0 2011 The Author(s)/Acta Paediatrica © 2011 Foundation Acta Paediatrica. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5386-d51ac18cd07d6325fa2abb5ebdc48e122a8108d58aa8f7407cd16d8ca05d55f73 |
Notes | ark:/67375/WNG-3FXW1G98-K ArticleID:APA2186 istex:E117BF6450F1A2E46B0FD92AEEFC49D2EB680300 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
PMID | 21284717 |
PQID | 1544874574 |
PQPubID | 866347 |
PageCount | 5 |
ParticipantIDs | swepub_primary_oai_DiVA_org_umu_42920 swepub_primary_oai_DiVA_org_liu_69187 proquest_miscellaneous_878820074 proquest_journals_1544874574 pubmed_primary_21284717 pascalfrancis_primary_24243112 crossref_citationtrail_10_1111_j_1651_2227_2011_02186_x crossref_primary_10_1111_j_1651_2227_2011_02186_x wiley_primary_10_1111_j_1651_2227_2011_02186_x_APA2186 istex_primary_ark_67375_WNG_3FXW1G98_K |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | July 2011 |
PublicationDateYYYYMMDD | 2011-07-01 |
PublicationDate_xml | – month: 07 year: 2011 text: July 2011 |
PublicationDecade | 2010 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: Norway – name: Stockholm |
PublicationTitle | Acta Paediatrica |
PublicationTitleAlternate | Acta Paediatr |
PublicationYear | 2011 |
Publisher | Blackwell Publishing Ltd Blackwell Wiley Subscription Services, Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Blackwell – name: Wiley Subscription Services, Inc |
References | DiSabatino A, Corazza GR. Coeliac disease. Lancet 2009; 373: 1480-93. Verdon CP, Burton BA, Prior RL. Sample pre-treatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite. Anal Biochem 1995; 224: 502-8. Spencer H, Daniels I, Shortland J, Long RG, Murray IA. Effect of a gluten-free diet on plasma nitric oxide products in coeliac disease. Scand J Gastroenterol 2004; 39: 941-5. Ravikumara M, Nootigattu VKT, Sandhu BK. Ninety percent of celiac disease is being missed. J Pediatr Gastroenterol Nutr 2007; 45: 497-9. Hörnell A. Living well with celiac disease? J Pediatr Gastroenterol Nutr 2008; 47: 544-6. Sobko T, Reinders CT, Janson E, Norin E, Midtvedt T, Lundberg JO. Gastrointestinal bacteria generate nitric oxide from nitrate and nitrite. Nitric Oxide 2005; 13: 272-8. Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK. Revised criteria for diagnosis of celiac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990; 65: 909-11. Myléus A, Ivarsson A, Webb C, Danielsson L, Hernell O, Högberg L, et al. Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr 2009; 49: 170-6. van Straaten E, Koster-Kamphuis L, Bovee-Oudenhoven I, van der Meer R, Forget P-P. Increased urinary nitric oxide oxidation products in children with active coeliac disease. Acta Paediatr 1999; 88: 528-31. van Doorn RK, Winkler LMF, Zwinderman KH, Mearin ML, Koopman HM. CDDUX: a disease specific health-related quality-of-life questionnaire for children with celiac disease. J Pediatr Gastroenterol Nutr 2008; 47: 147-52. Tjellström B, Stenhammar L, Högberg L, Fälth-Magnusson K, Magnusson K-E, Midtvedt T, et al. Gut microflora associated characteristics in children with celiac disease. Am J Gastroenterol 2005; 100: 2784-8. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (`coeliac sprue′). Gastroenterology 1992; 102: 330-54. Herulf M, Blomquist L, Ljung T, Weisberg E, Lundberg JO. Increased rectal nitric oxide in coeliac disease after local challenge with gluten. Scand J Gastroenterol 2001; 36: 169-73. Garrote JA, Gómez-González E, Bernardo D, Arranz E, Chirdo F. Celiac disease pathogenesis: the proinflammatory cytokine network. J Pediatr Gastroenterol Nutr 2008; 47: S27-32. West J, Logan RFA, Hill PG, Lloyd A, Lewis S, Hubbard R, et al. Seroprevalence, correlates, and characteristics of undetected celiac disease in England. Gut 2003; 52: 960-5. Holmgren Peterson K, Fälth-Magnusson K, Magnusson K-E, Stenhammar L, Sundqvist T. Children with celiac disease express inducible nitric oxide synthase in the small intestine during gluten challenge. Scand J Gastroenterol 1998; 33: 939-43. Matysiak-Budnik T, Malamut G, Patey-Mariaud deSerreN, Grosdidier E, Seguier S, Brousse N, et al. Long-term follow-up od coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet. Gut 2007; 56: 1379-86. Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005; 40: 1-19. Stenberg P, Roth EB, Sjöberg K. Transglutaminase and the pathogenesis of coeliac disease. Eur J Int Med 2008; 19: 83-91. Roediger WEW. Review article: nitric oxide from dysbiotic bacterial respiration of nitrate in the pathogenesis and as a target for therapy of ulcerative colitis. Aliment Pharmacol Ther 2008; 27: 531-41. Murray IA, Bullimore D, Long RG. Fasting plasma nitric oxide products in coeliac disease. Eur J Gastroenterol Hepatol 2003; 15: 1091-5. Kolios G, Valatas V, Ward SG. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 2004; 113: 427-37. Sundqvist T, Laurin P, Fälth-Magnusson K, Magnusson K-E, Stenhammar L. Significantly increased levels of nitric oxide products in urine of children with coeliac disease. J Pediatr Gastroenterol Nutr 1998; 27: 196-8. Webb C, Halvarsson B, Norström F, Myléus A, Carlsson A, Danielsson L, et al. Accuracy in celiac diagnostics by controlling the small bowel biopsy process. J Pediatr Gastroenterol Nutr 2011; [Epub ahead of print] Accepted for publication Pynnonen PA, Isometsa ET, Verkasalo MA, Kähkönen SA, Sipilä I, Savilahti E, et al. Gluten-free diet may alleviate depressive and behavioural symptoms in adolescents with coeliac disease: a prospective follow-up case-series study. BMC Psychiatry 2005; 5: 14-6. Daniels I, Cavill D, Murray IA, Long RG. Elevated expression of iNOS mRNA and protein in coeliac disease. Clin Chim Acta 2005; 356: 134-42. Fasano A. Clinical presentation of celiac disease in the pediatric population. Gastroenterology 2005; 128: S68-73. 1998; 27 1990; 65 2004; 113 2005; 100 2004; 39 2005; 356 1992; 102 2008; 19 2008; 27 2005; 128 2008; 47 2005; 40 2005; 5 1999; 88 2003; 15 1995; 224 2009; 373 2001; 36 2007; 45 2007; 56 2003; 52 2009; 49 1998; 33 2005; 13 e_1_2_8_27_2 e_1_2_8_28_2 e_1_2_8_23_2 e_1_2_8_24_2 e_1_2_8_25_2 e_1_2_8_26_2 e_1_2_8_9_2 e_1_2_8_2_2 e_1_2_8_4_2 e_1_2_8_3_2 e_1_2_8_6_2 e_1_2_8_5_2 e_1_2_8_8_2 e_1_2_8_7_2 e_1_2_8_20_2 e_1_2_8_21_2 e_1_2_8_22_2 e_1_2_8_16_2 e_1_2_8_17_2 e_1_2_8_18_2 e_1_2_8_19_2 e_1_2_8_12_2 e_1_2_8_13_2 Webb C (e_1_2_8_14_2) e_1_2_8_15_2 e_1_2_8_10_2 e_1_2_8_11_2 |
References_xml | – reference: West J, Logan RFA, Hill PG, Lloyd A, Lewis S, Hubbard R, et al. Seroprevalence, correlates, and characteristics of undetected celiac disease in England. Gut 2003; 52: 960-5. – reference: Spencer H, Daniels I, Shortland J, Long RG, Murray IA. Effect of a gluten-free diet on plasma nitric oxide products in coeliac disease. Scand J Gastroenterol 2004; 39: 941-5. – reference: Kolios G, Valatas V, Ward SG. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 2004; 113: 427-37. – reference: Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (`coeliac sprue′). Gastroenterology 1992; 102: 330-54. – reference: Garrote JA, Gómez-González E, Bernardo D, Arranz E, Chirdo F. Celiac disease pathogenesis: the proinflammatory cytokine network. J Pediatr Gastroenterol Nutr 2008; 47: S27-32. – reference: Hörnell A. Living well with celiac disease? J Pediatr Gastroenterol Nutr 2008; 47: 544-6. – reference: Sobko T, Reinders CT, Janson E, Norin E, Midtvedt T, Lundberg JO. Gastrointestinal bacteria generate nitric oxide from nitrate and nitrite. Nitric Oxide 2005; 13: 272-8. – reference: Murray IA, Bullimore D, Long RG. Fasting plasma nitric oxide products in coeliac disease. Eur J Gastroenterol Hepatol 2003; 15: 1091-5. – reference: Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK. Revised criteria for diagnosis of celiac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990; 65: 909-11. – reference: Herulf M, Blomquist L, Ljung T, Weisberg E, Lundberg JO. Increased rectal nitric oxide in coeliac disease after local challenge with gluten. Scand J Gastroenterol 2001; 36: 169-73. – reference: Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005; 40: 1-19. – reference: Pynnonen PA, Isometsa ET, Verkasalo MA, Kähkönen SA, Sipilä I, Savilahti E, et al. Gluten-free diet may alleviate depressive and behavioural symptoms in adolescents with coeliac disease: a prospective follow-up case-series study. BMC Psychiatry 2005; 5: 14-6. – reference: van Doorn RK, Winkler LMF, Zwinderman KH, Mearin ML, Koopman HM. CDDUX: a disease specific health-related quality-of-life questionnaire for children with celiac disease. J Pediatr Gastroenterol Nutr 2008; 47: 147-52. – reference: Ravikumara M, Nootigattu VKT, Sandhu BK. Ninety percent of celiac disease is being missed. J Pediatr Gastroenterol Nutr 2007; 45: 497-9. – reference: Tjellström B, Stenhammar L, Högberg L, Fälth-Magnusson K, Magnusson K-E, Midtvedt T, et al. Gut microflora associated characteristics in children with celiac disease. Am J Gastroenterol 2005; 100: 2784-8. – reference: Roediger WEW. Review article: nitric oxide from dysbiotic bacterial respiration of nitrate in the pathogenesis and as a target for therapy of ulcerative colitis. Aliment Pharmacol Ther 2008; 27: 531-41. – reference: Daniels I, Cavill D, Murray IA, Long RG. Elevated expression of iNOS mRNA and protein in coeliac disease. Clin Chim Acta 2005; 356: 134-42. – reference: Sundqvist T, Laurin P, Fälth-Magnusson K, Magnusson K-E, Stenhammar L. Significantly increased levels of nitric oxide products in urine of children with coeliac disease. J Pediatr Gastroenterol Nutr 1998; 27: 196-8. – reference: DiSabatino A, Corazza GR. Coeliac disease. Lancet 2009; 373: 1480-93. – reference: Holmgren Peterson K, Fälth-Magnusson K, Magnusson K-E, Stenhammar L, Sundqvist T. Children with celiac disease express inducible nitric oxide synthase in the small intestine during gluten challenge. Scand J Gastroenterol 1998; 33: 939-43. – reference: van Straaten E, Koster-Kamphuis L, Bovee-Oudenhoven I, van der Meer R, Forget P-P. Increased urinary nitric oxide oxidation products in children with active coeliac disease. Acta Paediatr 1999; 88: 528-31. – reference: Webb C, Halvarsson B, Norström F, Myléus A, Carlsson A, Danielsson L, et al. Accuracy in celiac diagnostics by controlling the small bowel biopsy process. J Pediatr Gastroenterol Nutr 2011; [Epub ahead of print] Accepted for publication – reference: Verdon CP, Burton BA, Prior RL. Sample pre-treatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite. Anal Biochem 1995; 224: 502-8. – reference: Stenberg P, Roth EB, Sjöberg K. Transglutaminase and the pathogenesis of coeliac disease. Eur J Int Med 2008; 19: 83-91. – reference: Matysiak-Budnik T, Malamut G, Patey-Mariaud deSerreN, Grosdidier E, Seguier S, Brousse N, et al. Long-term follow-up od coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet. Gut 2007; 56: 1379-86. – reference: Fasano A. Clinical presentation of celiac disease in the pediatric population. Gastroenterology 2005; 128: S68-73. – reference: Myléus A, Ivarsson A, Webb C, Danielsson L, Hernell O, Högberg L, et al. Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr 2009; 49: 170-6. – volume: 128 start-page: S68 year: 2005 end-page: 73 article-title: Clinical presentation of celiac disease in the pediatric population publication-title: Gastroenterology – volume: 47 start-page: 147 year: 2008 end-page: 52 article-title: CDDUX: a disease specific health‐related quality‐of‐life questionnaire for children with celiac disease publication-title: J Pediatr Gastroenterol Nutr – volume: 33 start-page: 939 year: 1998 end-page: 43 article-title: Children with celiac disease express inducible nitric oxide synthase in the small intestine during gluten challenge publication-title: Scand J Gastroenterol – volume: 47 start-page: 544 year: 2008 end-page: 6 article-title: Living well with celiac disease? publication-title: J Pediatr Gastroenterol Nutr – volume: 52 start-page: 960 year: 2003 end-page: 5 article-title: Seroprevalence, correlates, and characteristics of undetected celiac disease in England publication-title: Gut – article-title: Accuracy in celiac diagnostics by controlling the small bowel biopsy process publication-title: J Pediatr Gastroenterol Nutr – volume: 100 start-page: 2784 year: 2005 end-page: 8 article-title: Gut microflora associated characteristics in children with celiac disease publication-title: Am J Gastroenterol – volume: 15 start-page: 1091 year: 2003 end-page: 5 article-title: Fasting plasma nitric oxide products in coeliac disease publication-title: Eur J Gastroenterol Hepatol – volume: 102 start-page: 330 year: 1992 end-page: 54 article-title: Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (`coeliac sprue′) publication-title: Gastroenterology – volume: 40 start-page: 1 year: 2005 end-page: 19 article-title: Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition publication-title: J Pediatr Gastroenterol Nutr – volume: 36 start-page: 169 year: 2001 end-page: 73 article-title: Increased rectal nitric oxide in coeliac disease after local challenge with gluten publication-title: Scand J Gastroenterol – volume: 88 start-page: 528 year: 1999 end-page: 31 article-title: Increased urinary nitric oxide oxidation products in children with active coeliac disease publication-title: Acta Paediatr – volume: 113 start-page: 427 year: 2004 end-page: 37 article-title: Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle publication-title: Immunology – volume: 19 start-page: 83 year: 2008 end-page: 91 article-title: Transglutaminase and the pathogenesis of coeliac disease publication-title: Eur J Int Med – volume: 27 start-page: 531 year: 2008 end-page: 41 article-title: Review article: nitric oxide from dysbiotic bacterial respiration of nitrate in the pathogenesis and as a target for therapy of ulcerative colitis publication-title: Aliment Pharmacol Ther – volume: 47 start-page: S27 year: 2008 end-page: 32 article-title: Celiac disease pathogenesis: the proinflammatory cytokine network publication-title: J Pediatr Gastroenterol Nutr – volume: 49 start-page: 170 year: 2009 end-page: 6 article-title: Celiac disease revealed in 3% of Swedish 12‐year‐olds born during an epidemic publication-title: J Pediatr Gastroenterol Nutr – volume: 5 start-page: 14 year: 2005 end-page: 6 article-title: Gluten‐free diet may alleviate depressive and behavioural symptoms in adolescents with coeliac disease: a prospective follow‐up case‐series study publication-title: BMC Psychiatry – volume: 373 start-page: 1480 year: 2009 end-page: 93 article-title: Coeliac disease publication-title: Lancet – volume: 224 start-page: 502 year: 1995 end-page: 8 article-title: Sample pre‐treatment with nitrate reductase and glucose‐6‐phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite publication-title: Anal Biochem – volume: 27 start-page: 196 year: 1998 end-page: 8 article-title: Significantly increased levels of nitric oxide products in urine of children with coeliac disease publication-title: J Pediatr Gastroenterol Nutr – volume: 45 start-page: 497 year: 2007 end-page: 9 article-title: Ninety percent of celiac disease is being missed publication-title: J Pediatr Gastroenterol Nutr – volume: 65 start-page: 909 year: 1990 end-page: 11 article-title: Revised criteria for diagnosis of celiac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition publication-title: Arch Dis Child – volume: 13 start-page: 272 year: 2005 end-page: 8 article-title: Gastrointestinal bacteria generate nitric oxide from nitrate and nitrite publication-title: Nitric Oxide – volume: 56 start-page: 1379 year: 2007 end-page: 86 article-title: Long‐term follow‐up od coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet publication-title: Gut – volume: 39 start-page: 941 year: 2004 end-page: 5 article-title: Effect of a gluten‐free diet on plasma nitric oxide products in coeliac disease publication-title: Scand J Gastroenterol – volume: 356 start-page: 134 year: 2005 end-page: 42 article-title: Elevated expression of iNOS mRNA and protein in coeliac disease publication-title: Clin Chim Acta – ident: e_1_2_8_22_2 doi: 10.1080/00365520410003407 – ident: e_1_2_8_18_2 doi: 10.1097/00005176-200501000-00001 – ident: e_1_2_8_23_2 doi: 10.1111/j.1365-2567.2004.01984.x – ident: e_1_2_8_6_2 doi: 10.1016/j.cccn.2005.01.029 – ident: e_1_2_8_28_2 doi: 10.1097/MPG.0b013e31815ef87d – ident: e_1_2_8_2_2 doi: 10.1016/S0140-6736(09)60254-3 – ident: e_1_2_8_20_2 doi: 10.1016/j.niox.2005.08.002 – ident: e_1_2_8_26_2 doi: 10.1186/1471-244X-5-14 – ident: e_1_2_8_25_2 doi: 10.1111/j.1572-0241.2005.00313.x – ident: e_1_2_8_16_2 doi: 10.1136/gut.52.7.960 – ident: e_1_2_8_21_2 doi: 10.1097/00042737-200310000-00005 – ident: e_1_2_8_14_2 article-title: Accuracy in celiac diagnostics by controlling the small bowel biopsy process publication-title: J Pediatr Gastroenterol Nutr – ident: e_1_2_8_19_2 doi: 10.1006/abio.1995.1079 – ident: e_1_2_8_10_2 doi: 10.1097/MPG.0b013e3181818fb9 – ident: e_1_2_8_4_2 doi: 10.1016/j.ejim.2007.05.012 – ident: e_1_2_8_8_2 doi: 10.1111/j.1651-2227.1999.tb00169.x – ident: e_1_2_8_17_2 doi: 10.1136/adc.65.8.909 – ident: e_1_2_8_12_2 doi: 10.1097/MPG.0b013e31812e5710 – ident: e_1_2_8_7_2 doi: 10.1097/00005176-199808000-00013 – ident: e_1_2_8_11_2 doi: 10.1053/j.gastro.2005.02.015 – ident: e_1_2_8_27_2 doi: 10.1097/MPG.0b013e31817fcb7f – ident: e_1_2_8_24_2 doi: 10.1111/j.1365-2036.2008.03612.x – ident: e_1_2_8_5_2 doi: 10.1080/003655298750026958 – ident: e_1_2_8_3_2 doi: 10.1016/0016-5085(92)91819-P – ident: e_1_2_8_13_2 doi: 10.1097/MPG.0b013e31818c52cc – ident: e_1_2_8_9_2 doi: 10.1080/003655201750065924 – ident: e_1_2_8_15_2 doi: 10.1136/gut.2006.100511 |
SSID | ssj0023946 ssj0004374 |
Score | 2.0616312 |
Snippet | Aim: Increased concentration of nitric oxide (NO) metabolites, nitrite and nitrate, in the urine is a strong indication of ongoing small intestinal... Aim: Increased concentration of nitric oxide (NO) metabolites, nitrite and nitrate, in the urine is a strong indication of ongoing small intestinal... Increased concentration of nitric oxide (NO) metabolites, nitrite and nitrate, in the urine is a strong indication of ongoing small intestinal inflammation,... Aim: Increased concentration of nitric oxide (NO) metabolites, nitrite and nitrate, in the urine is a strong indication of ongoing small intestinal... |
SourceID | swepub proquest pubmed pascalfrancis crossref wiley istex |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1023 |
SubjectTerms | Biological and medical sciences Biomarkers - urine Biopsy Celiac disease Celiac Disease - blood Celiac Disease - diagnosis Celiac Disease - urine Child Coeliac disease Female Gastroenterology. Liver. Pancreas. Abdomen General aspects Humans Immunoglobulin A - blood Male Mass Screening - methods Medical sciences MEDICIN MEDICINE nitrate Nitrates Nitrates - urine Nitric oxide Nitric Oxide - urine Nitrites - urine Other diseases. Semiology Prevention and actions Public health. Hygiene Public health. Hygiene-occupational medicine Screening Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Transglutaminases - immunology Urinary nitrite Urinary nitrite/nitrate Urine |
Title | Children with screening-detected coeliac disease show increased levels of nitric oxide products in urine |
URI | https://api.istex.fr/ark:/67375/WNG-3FXW1G98-K/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1651-2227.2011.02186.x https://www.ncbi.nlm.nih.gov/pubmed/21284717 https://www.proquest.com/docview/1544874574 https://www.proquest.com/docview/878820074 https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-69187 https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-42920 |
Volume | 100 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1fb9MwELfQkBAv_P8TGJMfgLdUcR3HzmO10U2gTQgx1jfLsR0oLc3UNKLiiY_AZ-STcBenGUWTmBBvkZxL08v5_Dvf-XeEPM9d4sFOTOykTGKYiSY2HICctXkGAoyblqz6-CQ7Ok1fT8Skq3_CszCBH6LfcMOZ0fprnOCmqLcneSZYjGc5OyZObK80QDzJeIY0-gfvLpikUo4wpwvEeB4O8KiEQyAm-HaFz6VP3Vq2ruMXWGMZpalBk2VogXEZRu0JSLexb7t4jW-T2eZvh5qV2aBZFQP77Q9GyP-jlzvkVodx6SgY5V1yzS_ukRvHXRb_Pvm8350gp7gLTMFxQTANS-jP7z-cx6SGd9RW8BrG0i6BROtP1Vc6XSDGrWF4jrVONa1KCi4JXDmt1lPn6Xngr63hToppBP-AnI5fvd8_irueD7EF15vFTjBjmbIukS7jQ1GaoSkK4QtnU-UZWJViiXJCGaNKCdGodSxzyppEOCFKyR-SnUW18I8J5QZjOyZtynxq7DAXtvR55k3iZQm_FhG5-aTadoTo2Jdjrn8LjECVGlWpUZW6VaVeR4T1kueBFOQKMi9bq-kFzHKGRXVS6LOTQ83HkzN2mCv9JiJ7W2bVC-BBHg7wOCK7GzvTncOpNZIqYecCmUaE9sPgKjD_Yxa-amqtJIRTiBkj8iiY58WzA0yREXkR7LUfQfrxg-mHka6WH_V82ugsZ-pv9zVfGt32QYtI1trqldWkR29HePXkXwWfkpth2x8rqnfJzmrZ-GeAG1fFXusRfgFuUl1o |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1fb9MwELfQJgEv_GcExvAD8JYqruM4eawGXWFrhdDG-ma5tgNlpZmaRlQ88RH4jHwS7uI0o2gSE-ItknNpejmff-c7_46Q55mNHNiJDq2UUQgzUYeaA5AzJktAgHFdk1UPR8ngJH47FuOmHRCehfH8EO2GG86M2l_jBMcN6c1ZnggW4mHOhooT-yt1AFBu1-k6REjvL7ikYo5ApwnFeOaP8KQRh1BM8M0an0sfu7FwbeM3WGEhpS5Bl7lvgnEZSm0pSDfRb7189W-T2fqP-6qVs061nHTMtz84If-TZu6QWw3MpT1vl3fJNTe_R64Pm0T-ffJ5vzlETnEjmILvgngaVtGf339Yh3kNZ6kp4D20oU0OiZafiq90OkeYW8LwDMudSlrkFLwSeHNarKbW0XNPYVvCnRQzCe4BOem_Pt4fhE3bh9CA901CK5g2LDU2kjbhXZHrrp5MhJtYE6eOgWGlLEqtSLVOcwkBqbEssanRkbBC5JI_JFvzYu4eEco1hndMmpi5WJtuJkzussTpyMkcfi0gcv1NlWk40bE1x0z9FhuBKhWqUqEqVa1KtQoIayXPPS_IFWRe1mbTCujFGdbVSaFORweK98en7CBL1WFA9jbsqhXAszwcEHJAdteGphqfUyrkVcLmBTIOCG2HwVtgCkjPXVGVKpUQUSFsDMiOt8-LZ3ukIgPywhtsO4IM5K-mH3qqWHxUs2mlkoylf7uv-lKpuhVaQJLaWK-sJtV718Orx_8q-IzcGBwPj9TRm9HhE3LTZwGwwHqXbC0XlXsKMHI52avdwy80X2GG |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1fb9MwELfQJk288P9PYAw_AG-p4iaOncdqoxuMVRNirG-WazujtDRV04iKJz4Cn5FPwl2cZhRNYkK8VXIubS_n8-9yd78j5EVmIwd2okMrRBTCTtShjgHIGZOlIMBiXZNVnwzSo7Pk7ZAPm_on7IXx_BDtCzfcGbW_xg0-t_nmJk85C7GXs2HixPFKHcCT20kKpyYCpPeXVFJJjDinicTizHfwyCiGSIzHmyU-V95249zaxkewwjpKXYIqcz8D4yqQ2jKQboLf-vTq3yaT9f_2RSuTTrUcdcy3Pygh_49i7pBbDcilPW-Vd8kNN7tHdk6aNP598nm_aSGn-BqYgueCaBrO0J_ff1iHWQ1nqSngZ2hDmwwSLT8VX-l4hiC3hOUpFjuVtMgp-CTw5bRYja2jc09gW8KVFPMI7gE567_-sH8UNkMfQgO-Nw0tZ9owaWwkbBp3ea67ejTibmRNIh0Ds5IskpZLrWUuIBw1lqVWGh1xy3ku4odka1bM3GNCY43BHRMmYS7Rpptxk7ssdTpyIodvC4hYP1JlGkZ0HMwxVb9FRqBKhapUqEpVq1KtAsJayblnBbmGzKvaaloBvZhgVZ3g6nxwqOL-8JwdZlIdB2Rvw6xaAezkiQEfB2R3bWeq8TilQlYlHF0gkoDQdhl8BSaA9MwVVamkgHgKQWNAHnnzvLy3xykiIC-9vbYryD9-MP7YU8XiQk3HlUozJv92XfWlUvUgtICkta1eW02qd9rDT0_-VfA52Tk96Kt3bwbHT8lNnwLA6updsrVcVO4ZYMjlaK92Dr8AsVNgNQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Children+with+screening-detected+coeliac+disease+show+increased+levels+of+nitric+oxide+products+in+urine&rft.jtitle=Acta+paediatrica+%28Oslo%2C+Norway+%3A+1992%29&rft.au=H%C3%B6gberg%2C+L&rft.au=Webb%2C+C&rft.au=F%C3%A4lth-Magnusson%2C+K&rft.au=Forslund%2C+T&rft.date=2011-07-01&rft.eissn=1651-2227&rft.volume=100&rft.issue=7&rft.spage=1023&rft_id=info:doi/10.1111%2Fj.1651-2227.2011.02186.x&rft_id=info%3Apmid%2F21284717&rft.externalDocID=21284717 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0803-5253&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0803-5253&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0803-5253&client=summon |